牵头、重点参与局部晚期肺癌相关国际、国内多中心临床研究10项，参编相关国内/国际指南、专家共识3项。主持国家自然科学基金面上项目1项，国家重点研发计划子课题2项，省市级课题2项。申请人近5年以第一或共同通讯作者身份在Circulation Research, Advanced Functional Materials（2022）、Cancer letter（2022）、Biofabrication（2022）、Lung Cancer（2021）等中科院1区期刊共发表SCI论文13篇。
Led or played key roles in 10 international and domestic multicenter clinical studies on locally advanced lung cancer, and participated in the compilation of 3 related domestic/international guidelines and expert consensus publications. Presided over one National Natural Science Foundation of China (NSFC) General Program, two sub-projects of the National Key R&D Program, and two provincial/municipal-level research projects. In the past five years, the applicant has published 13 SCI-indexed papers as first author or co-corresponding author in Tier-1 journals of the Chinese Academy of Sciences, including Circulation Research (2025), Advanced Functional Materials (2022), Cancer Letters (2022), Biofabrication (2022), and Lung Cancer (2021).
